Sign in
Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas
Journal article   Open access  Peer reviewed

Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas

Michael J Ferguson, Steven D Rhodes, Li Jiang, Xiaohong Li, Jin Yuan, Xianlin Yang, Shaobo Zhang, Saeed T Vakili, Paul Territo, Gary Hutchins, …
Pediatric blood & cancer, Vol.63(2), pp.206-213
2016-02
PMCID: PMC4862309
PMID: 26375012

Abstract

Neurofibromatosis type 1 Plexiform neurofibroma Preclinical mouse model Receptor tyrosine kinase Sunitinib malate Therapy
url
https://doi.org/10.1002/pbc.25763View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.118 Soft Tissue, Bone & Nerve Cancers
1.118.1130 Schwannoma
Web Of Science research areas
Hematology
Oncology
Pediatrics
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details